Kaposi Sarcoma in Two Lung Transplant Recipients: A Single-Center Experience
Kaposi's Sarcoma (KS) is a malignant vascular tumor commonly seen in immunocompromised individuals, particularly patients with acquired immunodeficiency syndrome. Lung transplant recipients are at high risk of developing KS due to a strong immunosuppressive regimen that can lead to donor-derived infection or reactivation of recipient human herpesvirus 8, the causative organism for KS. In this overview, we describe 2 lung transplant recipients who developed pulmonary KS with poor outcomes, reviewing the diagnosis, bronchoscopy findings, and treatment and surveillance strategies for pulmonary KS.
Authors
- Atul C. Mehta (ORCID: https://orcid.org/0000-0001-5423-2147)
- Andrea V. Arrossi (ORCID: https://orcid.org/0000-0001-8256-0113)
- Olufemi Akindipe
- Sonali Sethi (ORCID: https://orcid.org/0000-0002-6136-2019)
- Jessica Lum (ORCID: https://orcid.org/0000-0001-6040-4304)
- Charles S. Lane (ORCID: https://orcid.org/0000-0001-8955-0276)
- J Turowski
- Wayne M. Tsuang (ORCID: https://orcid.org/0000-0001-7375-3845)
- Marie M Budev (ORCID: https://orcid.org/0000-0003-1575-3980)
- Avantika Nathani (ORCID: https://orcid.org/0009-0009-7484-6432)
- Shruti Gadre
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Transplantation Proceedings
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.transproceed.2024.07.004
- Citations
- 5
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.41